Quantcast
Last updated on April 24, 2014 at 16:36 EDT

Latest Metered-dose inhaler Stories

2014-04-04 12:27:51

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6ctxcw/smoking_cessation ) has announced the addition of the "Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Smoking cessation products are a better alternative for tobacco and cigarette addicts. Smoking cessation...

2014-03-10 23:04:07

The 47 billion-dollar worldwide respiratory device market continues to grow mainly due to the aging of the world population and increasing incidence of respiratory diseases, according to Kalorama Information in the new report “The World Market for Respiratory Devices.” New York, NY (PRWEB) March 10, 2014 The 47 billion-dollar worldwide respiratory device market continues to grow mainly due to the aging of the world population and increasing incidence of respiratory diseases, according...

2014-03-04 23:22:24

The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal - http://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html. (PRWEB) March 04, 2014 The "Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion...

2014-02-25 08:32:43

ALBANY, New York, February 25, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Pulmonary Drug Delivery Systems Market(Products- Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications- Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global pulmonary drug delivery systems market was valued at USD 21.03billion in 2012 and is expected to grow...

2014-02-19 16:25:14

VIENNA, Va., Feb. 19, 2014 /PRNewswire-USNewswire/ -- An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit patient education and advocacy organization. On Feb. 25, FDA's Nonprescription Drugs Advisory Committee and Pulmonary Allergy Drugs Committee will host a joint meeting to consider a new...

2014-01-23 04:21:29

OXFORD, England, January 23, 2014 /PRNewswire/ -- First clinical data from PSX1002, a novel, orally inhaled, drug-only, pMDI suspension formulation of glycopyrronium bromide, a long-acting muscarinic antagonist (LAMA) Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with...

2013-11-19 23:32:03

Achieve is conducting a safety and efficacy study on a new combination asthma treatment versus an inhaled treatment for adolescents and adult patients with asthma. Birmingham, Alabama (PRWEB) November 19, 2013 *To see if you qualify for this Asthma Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance is required, and you may receive compensation for...

2013-10-10 08:29:10

MORRISVILLE, North Carolina, October 10, 2013 /PRNewswire/ -- Cirrus Pharmaceuticals, Inc., NC, USA, a wholly owned subsidiary of Kemwell Biopharma Pvt. Ltd., announced that it was awarded a grant by the U.S. Food and Drug Administration entitled "Comprehensive Evaluation of Formulation Effects on Metered Dose Inhaler Performance". The goals of the program are to investigate the effects of excipient concentrations and API particle size on the aerosolization performance of...

2013-09-11 08:29:18

LISBON, Portugal, September 11, 2013 /PRNewswire/ -- Hovione announced today that the European Patent Office has granted a patent for Hovione's XCaps, a dry powder inhaler (DPI). XCaps addresses a pulmonary inhalation market need for a very inexpensive device which combines high efficiency in powder dispersion with ease of use. Lung fractions in excess of 70% have been achieved, from a device which only requires two steps to inhalation and which only has two components...

2013-08-25 23:02:00

This report provides insights into different aspects of the market such as competitive landscape, market dynamics, regulatory environment assessment, and market share analysis. It highlights high growth segments that represent enormous opportunities for existing players and new entrants. http://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html (PRWEB) August 25, 2013 The "Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free...


Latest Metered-dose inhaler Reference Libraries

Nicotine Replacement Therapy
2013-03-04 16:06:28

Nicotine replacement therapy is the administration of nicotine by other means than smoking. This change in the way nicotine is delivered prevents the harmful effects of smoking and is usually used in smoking cessation. Types Nicotine replacement therapy can be administered in several forms. The type used depends on the patient and what fits into their lifestyle best. The forms available include: Nicotine patches – transdermal (through the skin) Nicotine gum – orally (through the...

More Articles (1 articles) »